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Mesenchymal stem cell (MSC) based therapies are promising for a large spectrum of unmet medical needs. 
Despite this promise, the scaling-up of production of clinical grade MSCs is hindered by the use of planar 
technologies that require intensive labor and are not enough to meet market demands, as well as due to high 
product and process variability introduced by the use of xenogeneic materials. This work presents a new 
bioprocess and bioeconomics model of stem cell expansion to support informed decisions for stem cells process 
scaling up at reduced annual costs. The intrinsic equations and parameters that capture the cell biological 
features, according with their source and media used, are embedded in the model. A target number of cells per 
dose of 140 million and a GMP facility of 400 sq mt with 4 BSCs and 8 incubators will be used as the baseline 
for expansion of both bone marrow MSCs (BM-MSCs) and adipose stem cells (ASCs) using planar expansion 
technologies. The current standard medium for MSC culture containing fetal bovine serum (FBS) will be 
compared with the xeno-free alternative of human platelet lysate (hPL). The use of hPL for both cell sources 
results in an increase of the number of doses produced and a decrease of the cost of goods (CoG) per dose 
(Table 1). In order to improve the production capacity, 8 bioreactors with capacity up to 50L were input in the 
model, using xeno-free plastic microcarriers for cell adhesion and hPL as the culture medium. The model results 
indicate that the investment in the use of suspension cultures is valuable due to a considerable increase in the 
production and a decrease of CoG/dose. As the number of doses produced per year increases, the reagent 
costs dominate relatively to the facility costs (Fig. 1). Sensitivity analysis was performed by varying 11 model 
variables by +/- 33%. The main factors that influence annual capacity and CoGs are related to harvesting 
density and yield, growth rates and microcarrier area and concentration (Table 2). These findings may be used 
to improve the design of expansion methods with fully xeno-free materials and highlight the relevance of the 
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